A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Healthy Adults
Interventions: DRUG: Adagrasib|DRUG: Eltrombopag + adagrasib
Sponsor: Mirati Therapeutics Inc.